T2 Biosystems (NASDAQ:TTOO) Coverage Initiated at StockNews.com

Equities research analysts at StockNews.com began coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research report issued to clients and investors on Friday. The brokerage set a “sell” rating on the medical equipment provider’s stock.

T2 Biosystems Price Performance

Shares of TTOO opened at $0.11 on Friday. The company’s 50-day moving average is $0.13 and its 200-day moving average is $0.51. T2 Biosystems has a fifty-two week low of $0.06 and a fifty-two week high of $6.80.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.